KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Net Cash Flow: 2018-2025

Historic Net Cash Flow for BioNTech SE (BNTX) over the last 7 years, with Sep 2025 value amounting to -$182.5 million.

  • BioNTech SE's Net Cash Flow rose 78.94% to -$182.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $516.6 million, marking a year-over-year increase of 112.15%. This contributed to the annual value of -$2.1 billion for FY2024, which is 19.28% up from last year.
  • Latest data reveals that BioNTech SE reported Net Cash Flow of -$182.5 million as of Q3 2025, which was down 334.32% from $77.9 million recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Net Cash Flow ranged from a high of $5.0 billion in Q1 2022 and a low of -$2.9 billion during Q1 2024.
  • Moreover, its 3-year median value for Net Cash Flow was -$182.5 million (2025), whereas its average is -$387.2 million.
  • In the last 5 years, BioNTech SE's Net Cash Flow surged by 61,737,826.96% in 2021 and then plummeted by 311.61% in 2023.
  • Over the past 5 years, BioNTech SE's Net Cash Flow (Quarterly) stood at $342.5 million in 2021, then skyrocketed by 175.69% to $944.2 million in 2022, then tumbled by 311.61% to -$2.0 billion in 2023, then surged by 107.28% to $145.4 million in 2024, then skyrocketed by 78.94% to -$182.5 million in 2025.
  • Its last three reported values are -$182.5 million in Q3 2025, $77.9 million for Q2 2025, and $475.8 million during Q1 2025.